We are live on ! Find out more
D.E. Shaw & Co

D.E. Shaw & Co Portfolio holdings

AUM $166B
1-Year Est. Return 43.98%
 

D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.

This Fund
S&P 500
This Quarter Est. Return
+4.49%
1 Year Est. Return
+43.98%
3 Year Est. Return
+138.44%
5 Year Est. Return
+164.23%
10 Year Est. Return
+713.02%
AUM
$182B
AUM Growth
+$5.26B
Cap. Flow
-$3.52B
Cap. Flow %
-1.93%
Top 10 Hldgs %
11.63%
Holding
5,141
New
639
Increased
1,734
Reduced
1,574
Closed
583

Sector Composition

Rank Sector Weight
1 Technology 18.6%
2 Consumer Discretionary 9.12%
3 Healthcare 7.62%
4 Industrials 7.14%
5 Financials 6.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VISN
3076
PUT
Vistance Networks Inc
VISN
$2.79B
$1.69M ﹤0.01%
93,100
CP icon
3077
PUT
Canadian Pacific Kansas City
CP
$80.4B
$1.69M ﹤0.01%
+22,900
New +$1.69M
SAP icon
3078
CALL
SAP
SAP
$228B
$1.68M ﹤0.01%
+6,900
New +$1.76M
PI icon
3079
Impinj
PI
$4.99B
$1.67M ﹤0.01%
9,601
-7,628
-44% -$1.36M
LRMR icon
3080
Larimar Therapeutics
LRMR
$426M
$1.67M ﹤0.01%
+437,399
New +$1.7M
AMSF icon
3081
AMERISAFE
AMSF
$558M
$1.67M ﹤0.01%
43,353
+10,952
+34% +$442K
TEVA icon
3082
CALL
Teva Pharmaceuticals
TEVA
$40.5B
$1.66M ﹤0.01%
53,300
-79,400
-60% -$1.96M
WGO icon
3083
PUT
Winnebago Industries
WGO
$904M
$1.66M ﹤0.01%
41,000
-44,400
-52% -$1.62M
CTSH icon
3084
PUT
Cognizant
CTSH
$25.1B
$1.66M ﹤0.01%
20,000
SDHI
3085
Siddhi Acquisition Corp
SDHI
$365M
$1.66M ﹤0.01%
+161,578
New +$1.65M
AVIR icon
3086
Atea Pharmaceuticals
AVIR
$380M
$1.66M ﹤0.01%
464,787
+100,019
+27% +$318K
SRPT icon
3087
PUT
Sarepta Therapeutics
SRPT
$1.68B
$1.66M ﹤0.01%
77,100
-6,500
-8% -$137K
VNOM icon
3088
CALL
Viper Energy
VNOM
$8.09B
$1.65M ﹤0.01%
+42,800
New +$1.62M
PRGS icon
3089
PUT
Progress Software
PRGS
$1.73B
$1.65M ﹤0.01%
38,400
+29,500
+331% +$1.29M
FTAI icon
3090
FTAI Aviation
FTAI
$23B
$1.65M ﹤0.01%
+8,377
New +$1.43M
APTV icon
3091
CALL
Aptiv
APTV
$9.95B
$1.64M ﹤0.01%
21,600
HPE icon
3092
CALL
Hewlett Packard
HPE
$70.5B
$1.64M ﹤0.01%
68,400
+54,700
+399% +$1.29M
GPN icon
3093
PUT
Global Payments
GPN
$23.9B
$1.64M ﹤0.01%
21,200
-44,200
-68% -$3.56M
ACLX
3094
DELISTED
Arcellx
ACLX
$1.64M ﹤0.01%
+25,165
New +$2.01M
CNYA icon
3095
iShares MSCI China A ETF
CNYA
$204M
$1.64M ﹤0.01%
47,436
+9,313
+24% +$318K
CRS icon
3096
CALL
Carpenter Technology
CRS
$28.3B
$1.64M ﹤0.01%
5,200
-8,300
-61% -$2.5M
GHC icon
3097
Graham Holdings Company
GHC
$5.14B
$1.63M ﹤0.01%
1,487
FMC icon
3098
PUT
FMC
FMC
$1.35B
$1.63M ﹤0.01%
117,500
+18,300
+18% +$349K
KBA icon
3099
KraneShares Bosera MSCI China A 50 Connect Index ETF
KBA
$147M
$1.63M ﹤0.01%
52,649
+8,379
+19% +$254K
REAX icon
3100
Real Brokerage
REAX
$377M
$1.62M ﹤0.01%
445,183
+309,630
+228% +$1.2M

Similar funds

D.E. Shaw & Co's Q4 2025 Portfolio in Review

As of Q4 2025, D.E. Shaw & Co held 5,141 positions worth $182B, up 3% from $177B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

D.E. Shaw & Co's Q4 2025 filing shows 639 new, 1,734 increased, 1,574 reduced and 583 closed positions. Its largest new stake was iShares Core S&P 500 ETF: 1,175,000 shares worth $805M. The largest sale was Micron Technology, an estimated $1.31B.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • D.E. Shaw & Co's largest Q4 2025 buy was iShares Core S&P 500 ETF: 1,175,000 shares worth $805M.
  • D.E. Shaw & Co added most to Advanced Micro Devices in Q4 2025, an estimated $1.52B increase.
  • D.E. Shaw & Co's biggest Q4 2025 reduction was Micron Technology, cutting an estimated $1.31B.
  • D.E. Shaw & Co fully exited Vanguard Short-Term Corporate Bond ETF in Q4 2025, selling an estimated $499M.
  • D.E. Shaw & Co's ten largest holdings make up 12% of its $182B portfolio in Q4 2025.
  • D.E. Shaw & Co opened 639 new positions and closed 583 in Q4 2025.
  • D.E. Shaw & Co's portfolio value rose 3% quarter-over-quarter to $182B.

Based on D.E. Shaw & Co's 13F filing for Q4 2025, filed 17 Feb 2026.